Home Equities Score scPharmaceuticals Inc. (SCPH) stock soars during after-hour trading. Here’s the update.

scPharmaceuticals Inc. (SCPH) stock soars during after-hour trading. Here’s the update.

scPharmaceuticals Inc. (SCPH) stock gained by 7.34% at last close while the SCPH stock price surges by 2.13% in the after-hours trading session. SC Pharmaceuticals is a biopharmaceutical business specializing in the development and commercialization of medicines that aim to save healthcare expenditures and enhance health outcomes.

>> 7 Top Picks for the Post-Pandemic Economy << 

What is happening?

The FREEDOM-HF trial by SC pharmaceuticals yielded good top-line findings. FREEDOM-HF was a randomized controlled study that looked at the overall and heart failure-related costs of dealing with congestion in severe heart failure patients. Patients were treated with FUROSCIX, SCPH’s experimental medicine, after being discharged from the emergency department, versus a historical-comparative group who received intravenous furosemide in the inpatient hospital setting.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

Enrollment was stopped on May 17, 2021, before the goal of 34 patients, depending on the outcomes of a scheduled, prespecified interim research performed to verify the final sample size, and following input from statisticians, principal investigators, payer advisors, and Health Economics and Outcomes Research (HEOR) experts. The very statistically substantial decrease in 30-day heart failure-related expenses reported in patients who took FUROSCIX in the interim analysis led to this conclusion. Based on seven factors linked with hospitalization, the final analysis comprised 24 patients treated with FUROSCIX and 66 matched comparators.

Study Outcomes

  • The FUROSCIX group was shown to have a $17,753 mean difference in heart failure-related expenditures between the two groups, with a p-value of p0.0001 (95 percent CI: -$23,660, -$11,846), preferring the FUROSCIX group.
  • The difference in expenses was largely due to the cost of hospitalization. All individuals (24/24) who were recruited in the trial and administered FUROSCIX did not require an initial heart failure hospitalization, and all but one (95.8%) stayed out of the hospital for heart failure for the following 30-day period, as per protocol.
  • In the comparison group, all of the patients were admitted to the hospital at the outset, and 10.6% experienced a heart failure-related readmission.
  • Infusion site discomfort, bruising, and dizziness were the most prevalent side effects with FUROSCIX, although no major side effects were reported.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

SPX Flow Inc. (FLOW) stock surged during current market. Here’s why the stock is sky-rocketing?

SPX Flow Inc. (NASDAQ: FLOW) stock gained by 24.24% in the current market trading session. SPX FLOW, based in Charlotte, works to make the...

Platinum Group Metal Ltd. (PLG) stock surges during after-market trading. Here’s to know what’s happening?

Platinum Group Metal Ltd. (NASDAQ: PLG) stock declined by 8.54% at last close whereas the PLG stock price gains by 7% in the after-market...

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

Related News

TD Holdings Inc. (GLG) stock gains during current market trading. Here’s the recent update

TD Holdings Inc. (NASDAQ: GLG) stock gains by 5.01% in the current market trading session. TD Holdings, Inc. is a service provider in China...

NeuroMetrix Inc. (NURO) stock plunged during pre-market. Let’s find out why?

NeuroMetrix Inc. (NASDAQ: NURO) stock gained by 18.89% at last close while the NURO stock price losses by -4.12% in the pre-market trading session....

DMC Global Inc. (BOOM) stock declines during pre-market trading. Here’s what you should know

DMC Global Inc. (NASDAQ: BOOM) stock plunged by 6.50% at last close while the BOOM stock price fell further by 13.06% in the pre-market...

Boston Beer Company Inc. (SAM) stock fell during after-hour trading. Here’s the recent update

Boston Beer Company Inc. (NASDAQ: SAM) stock gains by 1.89% at last close whereas the SAM stock price plunged by 18.64% in the after-hours...

Jupiter Wellness, Inc. (JUPW) Stock Plummets Following Pricing of Underwritten Public Offering

Jupiter Wellness, Inc. (JUPW) stock prices were down 15.45% as of the market closing on July 21st, 2021, bringing the price per share down...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam